MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$155,534K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
Net loss
-180,585
Depreciation and amortization of property and equipment
7,193
Amortization of finance lease right of use asset
1,615
Stock-based compensation
30,947
Accretion of discount on investments, net
5,886
Change in fair value of warrant liabilities
0
Prepaid expenses and other assets
-939
Accounts payable and accrued expenses
-9,384
Operating lease liabilities and right of use assets, net
34
Finance lease liability
33
Other liabilities
-80
Net cash used in operating activities
-155,174
Purchases of investments
222,058
Proceeds from maturities of investments
289,760
Purchases of property and equipment
360
Net cash provided by investing activities
67,342
Issuance of common stock pursuant to exercise of stock options
0
Return of related party short swing profits
215
Repurchase of restricted stock units to satisfy tax withholding
67
Net cash provided by financing activities
148
Net change in cash, cash equivalents and restricted cash
-87,684
Cash and cash equivalents at beginning of period
164,997
Cash and cash equivalents at end of period
77,313
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

ROCKET PHARMACEUTICALS, INC. (RCKTW)

ROCKET PHARMACEUTICALS, INC. (RCKTW)